The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Inozyme Pharma, Inc(NASDAQ:INZY) 
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare gen...
Website: http://www.inozyme.com
Founded: 2015
CEO: Axel Bolte
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Inozyme Pharma Days Payable Outstanding ttm (DPO)
Inozyme Pharma Op Cashflow Per Share ttm
Inozyme Pharma Free Cashflow Per Share ttm
Inozyme Pharma Cash Per Share ttm
Inozyme Pharma (GAAP) P/E ratio ttm
Inozyme Pharma P/B ratio ttm
No extra charts and metrics for this ticker.